First Trust Indxx Medical Devices ETF

Elevatus Wealth Management Acquires 31,890 Shares of Edwards Lifesciences

Braidwell LP Increased Holdings of Globus Medical in Q2

Bellevue Group AG reduces its stake in Penumbra, Inc.

Financial Giants Conduct Significant Bullish Trades in Intuitive Surgical, Citigroup Downgrades Its Rating

Wells Fargo Raises Intuitive Surgical Target Price to $654

Waters Corp Underperformed Market with 9.4% CAGR Over Five Years

Qube Research & Technologies Acquires New Position in Penumbra in Q2

Edwards Lifesciences Vice President Sold 2,000 Shares

Marathon Capital Management Acquires 12,054 Shares of GE HealthCare Technologies

Frontier Capital Management Reduces Holdings in Align Technology

First Trust Advisors LP Increased Holdings in Penumbra, Inc.

Nova Scotia Bank Increases Holdings in Edwards Lifesciences, Executives Cut Holdings

Edward Lifesciences VP Reports Common Stock Disposition

Intuitive Surgical Executives Dispose of Common Stock

Intuitive Surgical's Da Vinci SP System Receives FDA Approval to Expand Application Scope

Imaging Biometrics Expands Global Distribution Agreement with GE HealthCare

Almac Group and others win 2025 Visionary Growth Leadership Best Practices Award

Vega Investment Solutions Reduces Holdings in Edwards Lifesciences

Align Technology Inc. Launches Invisalign Mandibular Advancement System in Thailand

Edwards Lifesciences VP Reports Sale of Common Stock

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

ISRG

Lazard Asset Management LLC increased its stake in Intuitive Surgical, Inc. by 0.4% in Q2, now holding 589,109 shares worth $320.13 million. Other institutional investors also adjusted their positions. Insiders sold 109,043 shares worth $60.82 million in the last 90 days. Analysts have mixed ratings on ISRG, with a consensus rating of 'Moderate Buy' and a price target of $608.79. Intuitive Surgical's Q3 earnings exceeded expectations with $2.51 billion in revenue and $2.40 EPS.

Market Beat

Lazard

Intuitive Surgical

Lazard Asset Management LLC Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

GMED

Braidwell LP acquired 247,200 shares of Globus Medical, valued at $14.59 million, during Q2. Other hedge funds also adjusted their positions. Insiders sold shares worth $8 million. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average target price of $93. Globus Medical's stock opened at $86.77, with a market cap of $11.61 billion. The company reported strong quarterly earnings, beating estimates with $1.18 EPS and $769.05 million revenue, up 22.9% YoY.

Globus Medical Inc 

Braidwell LP Purchases Shares of 247,200 Globus Medical, Inc. $GMED

Bellevue Group AG reduced its stake in Penumbra, Inc. by 14.9% in Q2, selling 30,467 shares. Penumbra's stock is rated "Moderate Buy" with an average target price of $309.75. Insiders sold 19,744 shares worth $5.76 million recently. Penumbra's stock opened at $312.41, with a market cap of $12.23 billion and a PE ratio of 74.74.

Penumbra

Bellevue Group AG Sells 30,467 Shares of Penumbra, Inc. $PEN

EXAS

Bellevue Group AG reduced its stake in Exact Sciences Corporation by 50.9% in Q2. Insider sales included 9,858 shares valued at $695,289. Analysts have mixed ratings, with an average "Hold" and target price of $85.00. Exact Sciences stock opened at $101.50, with a market cap of $19.23 billion and a 1-year high of $101.95.

Exact Sciences

Exact Sciences Corporation $EXAS Shares Sold by Bellevue Group AG

Adage Capital Partners GP L.L.C. increased its stake in Danaher Corporation by 2.2% in Q2, owning 1,002,895 shares worth $198.1M. Insider sales included SVP Brian W. Ellis and SVP Georgeann Couchara, totaling 30,248 shares sold. Analysts have mixed ratings, with a moderate buy consensus and an average target price of $246.79. Danaher opened at $226.70 on Friday.

Danaher

Adage Capital Partners GP L.L.C. Increases Stake in Danaher Corporation $DHR

Adage Capital Partners GP L.L.C. reduced its stake in Intuitive Surgical, Inc. by 4.4% in Q2, now holding 369,584 shares worth $200.84 million. Other institutional investors like Vanguard, State Street, and Geode also adjusted their positions. Insider transactions included significant sales by EVP Brian Miller and CEO David Rosa. Intuitive Surgical reported strong Q3 earnings, with a 22.9% revenue increase. Analysts remain positive, with Royal Bank of Canada setting a $625 price target.

Adage Capital Partners GP L.L.C. Has $200.84 Million Stock Holdings in Intuitive Surgical, Inc. $ISRG

Waters Corp. stock fell 1.75% to $385.33 on Friday, underperforming compared to competitors like Thermo Fisher Scientific and Danaher Corp. GE Aerospace rose 3.95%. The stock is 9.03% below its 52-week high. Trading volume was below average. The S&P 500 and Dow Jones also fell.

Dow Jones

Waters

Waters Corp. Stock Underperforms Friday When Compared To Competitors

The Cooper Companies Inc. announced that Brian G. Andrews, the company’s Executive Vice President, Chief Financial Officer, and Treasurer, has also taken on the role of principal accounting officer. Agostino Ricupati, who previously held that position, will continue as Senior Vice President, Tax.

Reuters

Cooper Cos

Cooper Companies CFO Brian Andrews Named Principal Accounting Officer

Danaher Corp.'s stock fell 2.60% to $226.33 on Friday, underperforming compared to competitors like Thermo Fisher Scientific and Abbott Laboratories. The stock closed 12.35% below its 52-week high, with trading volume surpassing its 50-day average. The broader market also saw declines, with the S&P 500 and Dow Jones Industrial Average both falling.

Danaher Corp. Stock Underperforms Friday When Compared To Competitors

Financial giants have made significant bullish moves on Intuitive Surgical (NASDAQ:ISRG) with 9 unusual options trades. 55% of traders were bullish, targeting a price range of $300 to $600. The mean open interest is 146.5 with a total volume of 70.00. Intuitive Surgical develops robotic systems for minimally invasive surgery, with over 10,000 installations worldwide. Current stock price is $547.13, with an average target price of $635.0. Citigroup downgraded its rating to Neutral with a new price target of $635.

benzinga_article

Smart Money Is Betting Big In ISRG Options

Danaher Corp's short interest has increased by 18.18%, now at 1.3% of available shares, indicating a bearish sentiment. It would take 2.24 days to cover these positions. Compared to peers, Danaher's short interest is lower, with the peer average at 7.67%. Increasing short interest can sometimes be bullish, as explained by Benzinga Money.

How Do Investors Really Feel About Danaher Corp?

Wells Fargo & Company raised its target price for Intuitive Surgical (NASDAQ:ISRG) from $600 to $654, maintaining an "overweight" rating, indicating a potential upside of 19.48%. Other brokerages also adjusted their price targets, with a consensus rating of "Moderate Buy" and a target price of $608.79. Intuitive Surgical reported strong quarterly earnings, beating estimates, and insiders have recently sold shares. Hedge funds have adjusted their positions in the company.

Wells Fargo & Company Issues Positive Forecast for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Waters Corporation (NYSE:WAT) shareholders have seen a 9.4% compound annual growth rate (CAGR) over the last five years, with a 56% increase in share price, which is below the market average. The company's earnings per share grew at 6.2% annually, indicating a positive market perception. Despite a 2.4% rise in the last year, this was below the market average. The company has a strong long-term track record, providing a 9% annual total shareholder return over five years.

Simplywall

Waters (NYSE:WAT) shareholders have earned a 9.4% CAGR over the last five years

Qube Research & Technologies Ltd acquired a new position in Penumbra, Inc. during the 2nd quarter, purchasing 209,710 shares valued at approximately $53.82 million. This acquisition represents 0.54% of Penumbra's stock. Other hedge funds also increased their holdings in Penumbra. Analysts have set new price targets for Penumbra, with a consensus rating of 'Moderate Buy' and a consensus price target of $309.75. Penumbra's stock recently traded at $312.01, with a market cap of $12.22 billion.

Qube Research & Technologies Ltd Invests $53.82 Million in Penumbra, Inc. $PEN

GEHC

GE HealthCare Technologies Inc.'s stock rose 1.87% to $86.05 on Thursday, outperforming the market. This marks the second consecutive day of gains, with the stock closing 9.23% short of its 52-week high of $94.80. Trading volume was slightly below the 50-day average. The S&P 500 and Dow Jones also saw gains.

GE HealthCare Tech

GE HealthCare Technologies Inc. Stock Rises Thursday, Outperforms Market